Carmen Navia
About Carmen Navia
Carmen Navia is a Research Associate II at Integral Molecular, specializing in antibody specificity analysis. She has experience working with SARS-CoV-2 antibodies and previously held positions at Franklin & Marshall College and Children's Hospital of Philadelphia.
Current Position at Integral Molecular
Carmen Navia serves as a Research Associate II at Integral Molecular, a position she has held since 2019. In this role, she focuses on the analysis of antibody specificity, particularly in the context of clinical trials. Her work involves handling client samples using the proprietary Membrane Protein Array (MPA), which is essential for understanding the interactions of antibodies with various antigens.
Previous Experience in Research and Laboratory Settings
Prior to her current role, Carmen Navia worked as a Research Technician at Children's Hospital of Philadelphia from 2018 to 2019. In this position, she contributed to various research projects within the Greater Philadelphia Area. Before that, she spent four years as a Laboratory Technician in Colon Cancer Biology at Franklin & Marshall College from 2014 to 2018, where she gained experience in laboratory techniques and cancer research.
Educational Background in Biochemistry and Molecular Biology
Carmen Navia earned her Bachelor’s Degree in Biochemistry and Molecular Biology from Franklin & Marshall College, completing her studies from 2014 to 2018. This educational background provided her with a solid foundation in the principles of biochemistry and molecular biology, which she applies in her current research endeavors.
Research Contributions During the COVID-19 Pandemic
During the COVID-19 pandemic, Carmen Navia worked with antibodies against the SARS-CoV-2 virus. This experience contributed to the understanding of immune responses to the virus and the development of potential therapeutic strategies. Her involvement in this critical area of research highlights her commitment to addressing public health challenges.
Independent Research Projects
Carmen Navia leads an independent project focused on analyzing the specificity of antibodies in clinical trials. This project aims to enhance the understanding of antibody interactions, which is vital for the development of effective therapies and diagnostics in various medical fields.